CDEK
← Mechanisms of action

CD33

SINGLE PROTEINHomo sapiens
Preferred name: Myeloid cell surface antigen CD33 ChEMBL ↗

Linked proteins

Drugs acting on this target (48)

Active Pharmaceutical Ingredient Mechanism Type ▲ Approval Status API Type Mechanism of Action
ave-9633Binding agentexperimentalmAbCD33 binding agent
bl-m11d1Binding agentexperimentalmAbCD33 binding agent
cd33*cd3 bsabBinding agentexperimentalmAbCD33
gemtuzumab ozogamicin (mylotarg)Binding agentapprovedmAbCD33 binding agent
gtb-360Binding agentexperimentalmAbCD33 binding agent
M195-geloninBinding agentexperimentalmAbCD33
oncolysin mBinding agentexperimentalmAbCD33 binding agent
bms-986497DegraderexperimentalmAbCD33 degrader
allogeneic cart-33Immunity, passiveexperimentalCell therapyCD33 immunity, passive
anti-cd33 car-nk cellsImmunity, passiveexperimentalCell therapyCD33 immunity, passive
car33Immunity, passiveexperimentalCell therapyCD33 immunity, passive
cart33Immunity, passiveexperimentalCell therapyCD33 immunity, passive
cc-96191Immunity, passiveexperimentalCell therapyCD33 immunity, passive
cd123-cd33 ccar t cellsImmunity, passiveexperimentalCell therapyCD33 immunity, passive
cd33 car-t cellsImmunity, passiveexperimentalCell therapyCD33 immunity, passive
cd33/cll1 dual car-nk cellImmunity, passiveexperimentalCell therapyCD33 immunity, passive
cll1-cd33 ccar t cellsImmunity, passiveexperimentalCell therapyCD33 immunity, passive
ibr733Immunity, passiveexperimentalCell therapyCD33 immunity, passive
lcar- f33sImmunity, passiveexperimentalCell therapyCD33 immunity, passive
lcar-amdrImmunity, passiveexperimentalCell therapyCD33 immunity, passive
mb-dnpm1-tcr.1Immunity, passiveexperimentalCell therapyCD33 immunity, passive
muc1/cll1/cd33/cd38/cd56/cd123-specific gene-engineered t cellsImmunity, passiveexperimentalCell therapyCD33 immunity, passive
prgn-3006 t cellsImmunity, passiveexperimentalCell therapyCD33 immunity, passive
sc-daric33Immunity, passiveexperimentalCell therapyCD33 immunity, passive
vcar33Immunity, passiveexperimentalCell therapyCD33 immunity, passive
vor33Immunity, passiveexperimentalCell therapyCD33 immunity, passive
a33InhibitorexperimentalmAbCD33 inhibitor
amg 330InhibitorexperimentalmAbCD33 inhibitor
amg 673InhibitorexperimentalmAbCD33 inhibitor
amv564InhibitorexperimentalmAbCD33 inhibitor
ave-9633InhibitorexperimentalmAbCD33 inhibitor
bi 836858InhibitorexperimentalmAbCD33 inhibitor
bi213 m195InhibitorexperimentalmAbCD33 inhibitor
clobetasol (dermovate)InhibitorapprovedmAbCD33 inhibitor
gem333InhibitorexperimentalmAbCD33 inhibitor
gemtuzumab ozogamicin (mylotarg)InhibitorapprovedmAbCD33 inhibitor
gtb-3550InhibitorexperimentalmAbCD33 inhibitor
imc-f106cInhibitorexperimentalmAbCD33 inhibitor
jnj-67571244InhibitorexperimentalmAbCD33 inhibitor
lintuzumabInhibitorexperimentalmAbCD33 inhibitor
mil95InhibitorexperimentalmAbCD33 inhibitor
mp0533InhibitorexperimentalRecombinant proteinCD33 inhibitor
oncolysin mInhibitorexperimentalmAbCD33 inhibitor
vadastuximab talirineInhibitorexperimentalmAbCD33 inhibitor
clobetasol (dermovate)OtherapprovedmAbCD33 other
lintuzumabOtherexperimentalmAbCD33 other
hum-195/rgelSupplementationexperimentalmAbCD33 supplementation
imgn779SupplementationexperimentalmAbCD33 supplementation